Depression in coronary heart disease patients: Etiological and screening issues

Current Psychiatry Reviews

Volumn 2, Issue 2, 2006, Pages 245-254

  Martin, Colin R ^a   Thompson, David R ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Cardiac rehabilitation (CR); CHD risk factor; PHQ 2; Selective serotonin re uptake inhibitor (SSRI); Sertraline anti depressant heart attack randomised; Trial (SADHART)

Indexed keywords

ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANXIETY DISORDER; ATHEROSCLEROSIS; BEHAVIOR THERAPY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; ISCHEMIC HEART DISEASE; MENTAL DISEASE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SCREENING TEST; SUPPORT GROUP;

EID: 33745862712     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340006776875923     Document Type: Review

References (150)

1. Watson R. Heart disease rising in central and eastern Europe. BMJ 2000; 320: 467.
2. Ferrari R, Visioli O. Stunning: damaging or protective to the myocardium? Cardiovasc Drugs Ther 1991; 5: 939-945.
3. Lewin B, Robertson IH, Cay EL, Irving JB, Campbell M. Effects of self-help post-myocardial-infarction rehabilitation on psychological adjustment and use of health services. Lancet 1992; 339: 1036-1040.
4. Lewin RJ, Thompson DR, Martin CR, et al. Validation of the Cardiovascular Limitations and Symptoms Profile (CLASP) in chronic stable angina. J Cardiopulm Rehabil 2002; 22: 184-191.
5. Lavoie KL, Fleet RP. The impact of depression on the course and outcome of coronary artery disease: review for cardiologists. Can J Cardiol 2000; 16: 653-662.
6. Steptoe A, Whitehead DL. Depression, stress, and coronary heart disease: the need for more complex models. Heart 2005; 91: 419-420.
7. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93: 1976-1980.
8. Wulsin LR. Is depression a major risk factor for coronary disease? A systematic review of the epidemiologic evidence. Harv Rev Psychiatry 2004; 12: 79-93.
9. Wulsin LF, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003; 65: 201-210.
10. Lesperance F, Frasure-Smith N. Depression and coronary artery disease: time to move from observation to trials. CMAJ 2003; 168: 570-571.
11. Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J Psychosom Res 2000; 48: 379-391.
12. Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 1999; 61: 26-37.
13. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005.
14. Mayou RA, Gill D, Thompson DR, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000; 62: 212-219.
15. Murchie P, Campbell NC, Ritchie LD, Deans HG, Thain J. Effects of secondary prevention clinics on health status in patients with coronary heart disease: 4 year follow-up of a randomised trial in primary care. Fam Pract 2004; 21: 567-574.
16. Lacey EA, Musgrave RJ, Freeman JV, Tod AM, Scott P. Psychological morbidity after myocardial infarction in an area of deprivation in the UK: evaluation of a self-help package. Eur J Cardiovasc Nurs 2004; 3: 219-224.
17. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005.
18. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66: 814-822.
19. Swenson JR. Quality of life in patients with coronary artery disease and the impact of depression. Curr Psychiatry Rep 2004; 6: 438-445.
20. Steele A, Wade TD. The contribution of optimism and quality of life to depression in an acute coronary syndrome population. Eur J Cardiovasc Nurs 2004; 3: 231-237.
21. Zellweger MJ, Osterwalder RH, Langewitz W, Pfisterer ME. Coronary artery disease and depression. Eur Heart J 2004; 25: 3-9.
22. Rumsfeld JS, Magid DJ, Plomondon ME, et al. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 2003; 145: 493-499.
23. Engblom E, Hamalainen H, Lind J, et al. Quality of life during rehabilitation after coronary artery bypass surgery. Qual Life Res 1992; 1: 167-175.
24. Mayou RA, Thompson DR, Clements A, et al. Guideline-based early rehabilitation after myocardial infarction. A pragmatic randomised controlled trial. J Psychosom Res 2002; 52: 89-95.
25. Cassano P, Fava M. Depression and public health: an overview. J Psychosom Res 2002; 53: 849-857.
26. Lewin RJ. Cardiac rehabilitation and primary care. Practitioner 2003; 247: 220-2, 224.
27. Lewin RJ, Thompson DR, Taylor RS. Cardiac rehabilitation. Eur Heart J 2000; 21: 860-861.
28. Lewin RJ. Cardiac rehabilitation and primary care. Practitioner 2003; 247: 220-2, 224.
29. Department of Health. Coronary heart disease: national service framework for coronary heart disease - modern standards and service models. London: Department of Health, 2000.
30. Lewin RJ, Thompson DR, Elton RA. Trial of the effects of an advice and relaxation tape given within the first 24 h of admission to hospital with acute myocardial infarction. Int J Cardiol 2002; 82: 107-114.
31. Furze G, Bull P, Lewin RJ, Thompson DR. Development of the York Angina Beliefs Questionnaire. J Health Psychol 2003; 8: 307-315.
32. Furze G, Roebuck A, Bull P, Lewin RJ, Thompson DR. A comparison of the illness beliefs of people with angina and their peers: a questionnaire study. BMC Cardiovasc Disord 2002; 2: 4.
33. Cassano P, Fava M. Depression and public health: an overview. J Psychosom Res 2002; 53: 849-857.
34. Sørensenf C, Friis-Hasché E, Haghfelt T, Bech P. Postmyocardial Infarction Mortality in Relation to Depression: A Systematic Critical Review. Psychother Psychosom 2005; 74: 69-80.
35. Barefoot JC, Brummett BH, Helms MJ, Mark DB, Siegler IC, Williams RB. Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med 2000; 62: 790-795.
36. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93: 1976-1980.
37. Barefoot JC. Depression and coronary heart disease. Cardiologia 1997; 42: 1245-1250.
38. Davidson DM. The family and cardiac rehabilitation. Journal of Family Practice 1979; 8: 253-261.
39. Cohen S, Rodriguez MS. Pathway linking affective disturbances and physical disorders. Health Psychol 1995; 14: 374-380.
40. Kubzansky LD, Kawachi I. Going to the heart of the matter: do negative emotions cause coronary heart disease? J Psychosom Res 2000; 48: 323-337.
41. Schneiderman N, Antoni MH, Saab PG, Ironson G. Health psychology: psychosocial and biobehavioural aspects of chronic disease management. Ann Rev Psychol 2001; 52: 555-580.
42. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med 2002; 23: 51-61.
43. Rowan PJ, Haas D, Campbell JA, Maclean DR, Davidson KW. Depressive symptoms have an independent, gradient risk for coronary heart disease incidence in a random, population-based sample. Ann Epidemiol 2005; 15: 316-320.
44. Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003; 54: 241-247.
45. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002; 53: 897-902.
46. Carney RM, Freedland KE, Jaffe AS. Depression as a risk factor for coronary heart disease mortality. Arch Gen Psychiatry 2001; 58: 229-230.
47. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66: 802-813.
48. Rowan PJ, Haas D, Campbell JA, Maclean DR, Davidson KW. Depressive symptoms have an independent gradient risk for coronary heart disease incidence in a random, population-based sample. Ann Epidemiol 2005; 15: 316-320.
49. Marzari C, Maggi S, Manzato E, et al. Depressive symptoms and development of coronary heart disease events: the Italian longitudinal study on aging. J Gerontol A Biol Sci Med Sci 2005; 60: 85-92.
50. Rafanelli C, Pancaldi LG, Ferranti G, et al. [Stressful life events and depressive disorders as risk factors for acute coronary heart disease]. Ital Heart J Suppl 2005; 6: 105-110.
51. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279-1283.
52. Douglas KM, Taylor AJ, O'Malley PG. Relationship between depression and C-reactive protein in a screening population. Psychosom Med 2004; 66: 679-683.
53. Albus C, Jordan J, Herrmann-Lingen C. Screening for psychosocial risk factors in patients with coronary heart disease-recommendations for clinical practice. Eur J Cardiovasc Prev Rehabil 2004; 11: 75-79.
54. Rees K, Bennett P, West R, Davey SG, Ebrahim S. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2004;(2): CD002902.
55. Olsson AG. Psychosocial factors and coronary heart disease. Curr Atheroscler Rep 2004; 6: 1-2.
56. Bunker SJ, Colquhoun DM, Esler MD, Hickie IB, Hunt D, Jelinek VM, Oldenburg BF, Peach HG, Ruth D, Tennant CC, Tonkin AM. "Stress" and coronary heart disease: psychosocial risk factors. Med J Aust 2003; 178: 272-276.
57. Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004; 66: 305-315.
58. O'Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 2004; 19: 397-403.
59. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201-217.
60. Schuld A, Schmid DA, Haack M, Holsboer F, Friess E, Pollmacher T. Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone. J Psychiatr Res 2003; 37: 463-470.
61. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279-1283.
62. Douglas KM, Taylor AJ, O'Malley PG. Relationship between depression and C-reactive protein in a screening population. Psychosom Med 2004; 66: 679-683.
63. Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004; 161: 271-277.
64. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279-1283.
65. Strike PC, Magid K, Brydon L, Edwards S, McEwan JR, Steptoe A. Exaggerated platelet and hemodynamic reactivity to mental stress in men with coronary artery disease. Psychosom Med 2004; 66: 492-500.
66. Loew M, Hoffmann MM, Hahmann H, Marz W, Rothenbacher D, Brenner H. Smoking, apolipoprotein E genotype, and early onset of coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005; 12: 268-270.
67. Wittchen HU, Glaesmer H, Marz W, et al. Cardiovascular risk factors in primary care: methods and baseline prevalence rates- the DETECT program. Curr Med Res Opin 2005; 21: 619-630.
68. Whiteley L, Padmanabhan S, Hole D, Isles C. Should Diabetes Be Considered a Coronary Heart Disease Risk Equivalent?: Results from 25 years of follow-up in the Renfrew and Paisley Survey. Diabetes Care 2005; 28: 1588-1593.
69. Ziegler D. Type 2 diabetes as an inflammatory cardiovascular disorder. Curr Mol Med 2005; 5: 309-322.
70. Ballantyne C, Arroll B, Shepherd J. Lipids and CVD management: towards a global consensus. Eur Heart J 2005.
71. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385-390.
72. Freedland KE, Carney RM, Skala JA. Depression and smoking in coronary heart disease. Psychosom Med 2005; 67 (Suppl 1): S42-S46.
73. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005; 28: 1339-1345.
74. Otsuka K, Yamanaka G, Shinagawa M, et al. Chronomic community screening reveals about 31% depression, elevated blood pressure and infradian vascular rhythm alteration. Biomed Pharmacother 2004; 58 Suppl 1: S48-S55.
75. Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C, Toutouzas P. Risk stratification of coronary heart disease in Greece: final results from the CARDIO2000 Epidemiological Study. Prev Med 2002; 35: 548-556.
76. Chrysohoou C, Panagiotakos DB, Pitsavos C, et al. Gender differences on the risk evaluation of acute coronary syndromes: the CARDIO2000 study. Prev Cardiol 2003; 6: 71-77.
77. Roose SP. Depression, anxiety, and the cardiovascular system: the psychiatrist's perspective. J Clin Psychiatry 2001; 62 (Suppl 8): 19-22.
78. Jiang W, Krishnan RR, O'Connor CM. Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs 2002; 16: 111-127.
79. Burg MM, Abrams D. Depression in chronic medical illness: the case of coronary heart disease. J Clin Psychol 2001; 57: 1323-1337.
80. Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J Psychosom. Res 2000; 48: 379-391.
81. Lane D, Carroll D, Lip GY. Psychology in coronary care. QJM 1999; 92: 425-431.
82. Shapiro PA. Psychiatric aspects of cardiovascular disease. Psychiatr Clin North Am 1996; 19: 613-629.
83. Schneiderman N, Saab PG, Catellier DJ, et al Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. Psychosom Med 2004; 66: 475-483.
84. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomised Trial. JAMA 2003; 289: 3106-3116.
85. Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004; 66: 466-474.
86. Sheps DS, Freedland KE, Golden RN, McMahon RP. ENRICHD and SADHART: implications for future biobehavioural intervention efforts. Psychosom Med 2003; 65: 1-2.
87. Froelicher ES, Miller NH, Buzaitis A, et al. The Enhancing Recovery in Coronary Heart Disease Trial (ENRICHD): strategies and techniques for enhancing retention of patients with acute myocardial infarction and depression or social isolation. J Cardiopulm Rehabil 2003; 23: 269-280.
88. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomised Trial. JAMA 2003; 289: 3106-3116.
89. Swenson JR, O'Connor CM, Barton D, et al. Influence of depression and effect of treatment with sertraline on quality of life after hospitalisation for acute coronary syndrome. Am J Cardiol 2003; 92: 1271-1276.
90. Coupland N, Wilson S, Nutt D. Antidepressant drugs and the cardiovascular system: a comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems. J Psychopharmacol 1997; 11: 83-92.
91. Glassman AH, Davis JM. Modern tricyclic antidepressant drugs are hardly distinguishable in efficacy or safety for treatment of depressive mood disorders in controlled clinical trials. J Clin Psychopharmacol 1993; 13: 296-299.
92. Glassman AH, Roose SP, Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 1993; 269:2673-2675.
93. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709.
94. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709.
95. Glassman AH, O'Connor CM, Califf RM, et al. Sentraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709.
96. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 136: 765-776.
97. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial. BMJ 1996; 313: 1517-1521.
98. World Health Organisation. Needs and Action Priorities in Cardiac Rehabilitation and Secondary Prevention in Patients with CHD. Geneva: WHO Regional Office for Europe, 1993.
99. Grace SL, Abbey SE, Pinto R, Shnek ZM, Irvine J, Stewart DE. Longitudinal course of depressive symptomatology after a cardiac event: effects of gendŗ and cardiac rehabilitation. Psychosom Med 2005; 67: 52-58.
100. Grace SL, Abbey SE, Pinto R, Shnek ZM, Irvine J, Stewart DE. Longitudinal course of depressive symptomatology after a cardiac event: effects of gender and cardiac rehabilitation. Psychosom Med 2005; 67: 52-58.
101. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996; 156: 745-752.
102. Martin CR. What does the Hospital Anxiety and Depression Scale (HADS) Really Measure in Liaison Psychiatry Settings? Curr Psychiatry Rev 2005; 1:69-73.
103. Jomeen J, Martin CR. Confirmation of an occluded anxiety component within the Edinburgh Postnatal Depression Scale (EPDS) during early pregnancy. J Reprod Infant Psychol 2005; 23, 143-154.
104. Martin CR, Newell RJ. The factor structure of the 12-item General Health Questionnaire (GHQ- 12) in individuals with facial disfigurement. J Psychosom Res in press. 2005.
105. Crawford JR, Henry JD, Crombie C, Taylor EP. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 2001; 40: 429-434.
106. Hare DL, Davis CR. Cardiac Depression Scale: validation of a new depression scale for cardiac patients. J Psychosom Res 1996; 40: 379-386.
107. Lewin RJ, Thompson DR, Martin CR, et al. Validation of the Cardiovascular Limitations and Symptoms Profile (CLASP) in chronic stable angina. J Cardiopulm Rehabil 2002; 22: 184-191.
108. Hare DL, Davis CR. Cardiac Depression Scale: validation of a new depression scale for cardiac patients. J Psychosom Res 1996; 40: 379-386.
109. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
110. Snaith RP. The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes 2003; 1: 29.
111. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
112. Barth J, Martin CR. Factor structure of the Hospital Anxiety and Depression Scale (HADS) in German coronary heart disease patients. Health Qual Life Outcomes 2005; 3: 15.
113. Martin CR, Thompson DR, Chan DS. An examination of the psychometric properties of the Hospital Anxiety and Depression Scale in Chinese patients with acute coronary syndrome. Psychiatry Res 2004; 129: 279-288.
114. Martin CR, Lewin RJP, Thompson DR. A confirmatory factor analysis of the Hospital Anxiety and Depression Scale in coronary care patients following acute myocardial infarction. Psychiatry Res 2003; 120: 85-94.
115. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
116. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996; 67: 588-597.
117. Steer RA, Ball R, Ranieri WF, Beck AT. Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol 1999; 55: 117-128.
118. Steer RA, Clark DA, Beck AT, Ranieri WF. Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav Res Ther 1999; 37: 183-190.
119. Hamm LF, Kavanagh T, Campbell RB, et al. Timeline for peak improvements during 52 Weeks of outpatient cardiac rehabilitation. J Cardiopulm Rehabil 2004; 24: 374-380.
120. Lavoie KL, Fleet RP, Lesperance F, et al. Are exercise stress tests appropriate for assessing myocardial ischemia in patients with major depressive disorder? Am Heart J 2004; 148: 621-627.
121. Valkamo M, Koivumaa-Honkanen HT, Hintikka J, Niskanen L, Honkalampi K, Viinamaki H. Life satisfaction in patients with chest pain subsequently diagnosed as coronary heart disease-connection through depressive symptoms? Qual Life Res 2003; 12: 1099-1105.
122. Jomeen J, Martin CR. Is the Hospital Anxiety and Depression Scale (HADS) a reliable screening tool in early pregnancy? Psychol Health 2004; 19: 787-800.
123. Campbell IM, Burgess PM, Finch SJ. A factorial analysis of BDI scores. J Clin Psychol 1984; 40: 992-996.
124. Goldberg D, Williams PA. Users Guide to General Health Questionnaire. Windsor: NFER-Nelson, 1988.
125. Goldberg DP, Gater R, Sartorius N, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 1997; 27: 191-197.
126. Goldberg DP, Gater R, Sartorius N, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 1997; 27: 191-197.
127. Werneke U, Goldberg DP, Yalcin I, Ustun BT. The stability of the factor structure of the General Health Questionnaire. Psychol Med 2000; 30: 823-829.
128. Plummer SE, Gournay K, Goldberg D, Ritter SA, Mann AH, Blizard R. Detection of psychological distress by practice nurses in general practice. Psychol Med 2000; 30: 1233-1237.
129. Werneke U, Goldberg DP, Yalcin I, Ustun BT. The stability of the factor structure of the General Health Questionnaire. Psychol Med 2000; 30: 823-829.
130. Martin CR, Jomeen J. Is the 12-item General Health Questionnaire (GHQ-12) confounded by scoring method during pregnancy and following birth? J Reprod Infant Psychol 2003; 21: 267-278.
131. Martin CR, Newell RJ. Is the 12-item General Health Questionnaire (GHQ-12) confounded by scoring method in individuals with facial disfigurement? Psychol Health 2005;in press.
132. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001; 66: 159-164.
133. McHorney CA, Monahan PO. Postscript: Applications of Rasch analysis in health care. Med Care 2004; 42(1 Suppl): 173-178.
134. Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med 2003; 33: 351-356.
135. Sorensen C, Brandes A, Hendricks O, Thrane J, Friis-Hasche E, Haghfelt T, Bech P. Psychosocial predictors of depression in patients with acute coronary syndrome. Acta Psychiatr Scand 2005; 111: 116-124.
136. Hare DL, Davis CR. Cardiac Depression Scale: validation of a new depression scale for cardiac patients. J Psychosom Res 1996; 40: 379-386.
137. Hare DL, Davis CR. Cardiac Depression Scale: validation of a new depression scale for cardiac patients. J Psychosom Res 1996; 40: 379-386.
138. Birks Y, Roebuck A, Thompson DR. A validation study of the Cardiac Depression Scale (CDS) in a UK population. Br J Health Psychol 2004; 9(Pt 1): 15-24.
139. Birks Y, Roebuck A, Thompson DR. A validation study of the Cardiac Depression Scale (CDS) in a UK population. Br J Health Psychol 2004; 9(Pt 1): 15-24.
140. Birks Y, Roebuck A, Thompson DR. A validation study of the Cardiac Depression Scale (CDS) in a UK population. Br J Health Psychol 2004; 9(Pt 1): 15-24.
141. Hare DL, Davis CR. Cardiac Depression Scale: validation of a new depression scale for cardiac patients. J Psychosom Res 1996; 40: 379-386.
142. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003; 41: 1284-1292.
143. Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965; 13: 508-515.
144. Carroll BJ, Feinberg M, Smouse PE, Rawson SG, Greden JF. The Carroll rating scale for depression. I. Development, reliability and validation. Br J Psychiatry 1981; 138: 194-200.
145. Smouse PE, Feinberg M, Carroll BJ, Park MH, Rawson SG. The Carroll rating scale for depression. II. Factor analyses of the feature profiles. Br J Psychiatry 1981; 138: 201-204.
146. Feinberg M, Carroll BJ, Smouse PE, Rawson SG. The Carroll rating scale for depression. III. Comparison with other rating instruments. Br J Psychiatry 1981; 138: 205-209.
147. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782-786.
148. Sanderson BK, Southard D, Oldridge N. AACVPR consensus statement. Outcomes evaluation in cardiac rehabilitation/ secondary prevention programs: improving patient care and program effectiveness. J Cardiopulm Rehabil 2004; 24: 68-79.
149. Herridge ML, Stimler CE, Southard DR, King ML. Depression screening in cardiac rehabilitation: AACVPR Task Force Report. J Cardiopulm Rehabil 2005; 25: 11-13.
150. Harpole LH, Williams JW Jr, Olsen MK, et al. Improving depression outcomes in older adults with comorbid medical illness. Gen Hosp Psychiatry 2005; 27: 4-12.